PSCore platform delivered over 500 characterized iPSC lines during first year of collaboration . SAN DIEGO, CA, 11 March 2026 ...
On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results